Search

everythinglearnresearchcommunity

for

Search:↓

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Many women experience sexual dysfunction, but few seek help, and better treatment and medical training are needed.

Melatonin may help treat PCOS symptoms in rats.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

Finasteride doesn't affect ovulation in normal women.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

More research is needed to understand how testosterone is maintained in adult males.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The scalp's microorganisms significantly affect hair health and disease.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.